内镜鼻窦手术后的疼痛与阿片类药物消耗:一项前瞻性队列研究
该前瞻性观察性队列纳入2019年11月至2020年3月接受内镜鼻窦手术的91例患者,均予10片5 mg羟考酮(75 MME)。平均阿片类药物使用量为35.2±47.3 MME,29例(32%)术后未使用阿片类药物,6例(7%)需追加处方。术前焦虑、术前疼痛及对术后疼痛的预期与术后阿片类药物使用相关。
要点
- 91例内镜鼻窦手术患者平均阿片类药物使用量为35.2±47.3 MME。
- 29例(32%)术后未使用任何阿片类药物,6例(7%)需追加阿片类药物处方。
- 术前焦虑、术前疼痛及对术后疼痛的预期与术后阿片类药物使用相关。
核心结论
- 多数患者在内镜鼻窦手术后阿片类药物使用量很少,疼痛似乎影响术后前4天内的阿片类药物使用。
- 焦虑患者可能从替代疼痛管理策略中获益以减少阿片类药物消耗。
研究设计与样本
- 前瞻性观察性队列研究,纳入2019年11月至2020年3月接受内镜鼻窦手术的患者,最终队列91例。
- 基线收集人口学数据及术前焦虑、疼痛和术后疼痛预期信息,阿片类药物使用量换算为毫克吗啡当量(MME)。
- 所有患者接受10片5 mg羟考酮(75 MME),通过每48小时电话随访量化术后疼痛和阿片类药物消耗,主要结局为总MME使用量。
主要发现
- 平均阿片类药物使用量为35.2±47.3 MME。
- 29例(32%)患者术后未使用任何阿片类药物,6例(7%)患者需要追加阿片类药物处方。
- 术后阿片类药物使用与术前焦虑增加相关(r=0.41,P<.001)、与术前疼痛相关(r=0.28,P=.007)、与对术后疼痛的预期相关(r=0.36,P<.001)。
- 术后疼痛增加仅与术后第0-2天(r=0.33,P=.001)和第3-4天(r=0.59,P<.001)的阿片类药物使用增加相关。
- 多变量回归中,既往吸烟(β=23.4 MME,SE=10.1,95%CI:3.3-43.5,P=.023)和焦虑(β=35.9,SE=10.2,95%CI:15.6-56.3,P<.001)与MME增加相关。
临床怎么用
- 作者认为多数患者在内镜鼻窦手术后阿片类药物使用量很少,疼痛似乎影响术后前4天内的阿片类药物使用。
- 作者认为焦虑患者可能从替代疼痛管理策略中获益以减少阿片类药物消耗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Surgeons have a critical role in the current opioid epidemic, and there is a need to prospectively understand patterns of pain and opioid use among patients undergoing endoscopic sinus surgery (ESS). STUDY DESIGN: Prospective observational cohort. METHODS: This was a prospective, observational cohort study that included patients undergoing ESS from November 2019 to March 2020. Demographic data were collected at baseline, as was respondent information regarding preoperative anxiety, pain, and postoperative pain expectations. Opioid use was converted to milligram morphine equivalents (MME). All patients received 10 tablets of 5 mg oxycodone (75 MME). Patients quantified postoperative pain and opioid consumption via telephone follow-up every 48 hours. The primary outcome was total MME utilized. RESULTS: There were 91 patients included in the final cohort. Mean opioid use was 35.2 ± 47.3 MME. There were 29 (32%) patients who did not use any opioids after surgery, and six (7%) patients who required opioid refills. Postoperative opioid use was associated with increased preoperative anxiety (r = 0.41, P < .001), preoperative pain (r = 0.28, P = .007), and expectations for postoperative pain (r = 0.36, P < .001). Increased postoperative pain was only associated with increased opioid use on postoperative days 0-2 (r = 0.33, P = .001) and 3-4 (r = 0.59, P < .001). On multivariate regression, former smoking (β = 23.4 MME, SE = 10.1, 95% confidence interval [CI]: 3.3-43.5, P = .023) and anxiety (β = 35.9, SE = 10.2, 95% CI: 15.6-56.3, P < .001) were associated with increased MME. CONCLUSIONS: The majority of patients have minimal opioid use after ESS, and pain appears to influence opioid use within the first 4 days after surgery. Additionally, patients with anxiety may benefit from alternative pain management strategies to mitigate opioid consumption. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:2096-2102, 2022.
引用
- Pandrangi VC, Scott BL, Pailet J, et al. Pain and Opioid Consumption Following Endoscopic Sinus Surgery: A Prospective Cohort Study. Laryngoscope. 2021. PMID: 34843110. doi:10.1002/lary.29967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。